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Genome-wide association study identifies 74 loci associated with educational attainment
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It is generally assumed that social and other environmental factors like poverty are involved in
educational attainment. However, a recently published genome-wide association study (GWAS) for
educational attainment of 293,723 individuals (Okbay et al., 2016) identified 74 loci associated with
the number of years of schooling completed, with eight of them showing the highest association.
One of these genes showing a single-nucleotide polymorphism (SNP) linked to educational
attainment was located on chromosome 17. The SNP was rs192818565 (dbSNP ID: has merged
into rs62056842 T/G) in position chr17:45914149 (according to GRCh38.p7 assembly of human
genome), located within the first intron on the MAPT gene (microtubule associated protein tau,
Figure 1A; http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=62056842).
The human tau gene is located on chromosome 17: 45,894,382–46,028,334, and it contains
16 exons that by historical reasons have been numbered as shown in Figure 1A. Tau is mainly
expressed in neurons, and by alternative splicing of exons 2, 3, and 10 yields different mRNA
species in the central nervous system (Andreadis, 2005). Alternative splicing of exon 10 produces
tau isoforms with either three (3R-tau, lacking exon 10) or four (4R–tau, including exon
10) tubulin/microtubule binding repeats. The locus where MAPT gene is present has been
divided into two haplotypes, H1 and H2. Haplotype H2 is inverted with respect to H1. The
inversion encompasses a number of genes (CRHR1, IMP5, MAPT, and NSF) and the absence of
recombination between them has resulted in both haplotypes defined among other marks by 8
SNP (for a review see Caffrey and Wade-Martins, 2007). Non-inverted H1 haplotypes are more
susceptibility to tauopathies and its promoter is more efficient at transcription level compared with
H2 promoter (Kwok et al., 2004).
Tau protein is altered in many diseases, from Alzheimer’s disease (AD) to Parkinson’s
disease (PD) and, as has been recently described, Huntington’s disease (Avila et al., 2004;
Fernández-Nogales et al., 2014; Iqbal et al., 2016). Tau missense mutations have been described
in FTDP-17 while in other tauopathies tau levels or the 3R/4R-tau ratio are altered. While
SNPs are roughly homogeneously distributed throughout the gene (Figure 1A, light blue
boxes), clinical association studies have shown that SNPs labeled as “probably pathogenic”
or “pathogenic” are mainly located at the 3′-end of the gene, where the coding exons are
located (Figure 1A, purple boxes, http://www.ncbi.nlm.nih.gov/projects/SNP/). Conversely, the
first intron where the SNP linked to educational attainment was located, has few of those.
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FIGURE 1 | MAPT gene. A single tau gene located on the human chromosome 17 is transcribed into the corresponding nuclear RNA that, by alternative splicing,
yields several tau mRNAs. (A) Exons are labeled in red numbers. Sth indicates the existence of a DNA sequence encoding the protein saithoin within the intron
between exons 9 and 10. ncRNAs MAPT-AS1, MAPT-IT1 and likely LOC105371800 are shown. Light blue boxes: SNP present in MAPT gene; purple boxes: SNP
labeled as “probable pathogenic” or “pathogenic”; red and orange boxes: SNPs that genetic association studies have linked to a strong risk to major diseases
(Parkinson disease –rs17563986- and progressive supranuclear palsy –rs242557-). Some SNPs used to describe MAPT haplotypes are flanking the SNP here
commented on (rs62056842) and are located within that first intron (rs1467967 and rs242557). (B) Allele frequencies of SNP rs192818565 in diverse human
populations (rs544990728 in 1000 genomes data base). Data and images have been taken from https://www.ncbi.nlm.nih.gov/variation/tools/1000genomes/.
Interestingly, genetic association studies have found associations
between SNPs in the first intron (close to rs62056842; Figure 1A,
red and orange boxes) and a strong associated risk to major
diseases. Furthermore, two SNPs used to describe MAPT
haplotypes are flanking the abovementioned SNP and are located
within that first intron (rs1467967-position chr17:45908813- and
rs242557 –position chr17:45942346-) (Myers et al., 2007).
Few studies have focused on intron 0. As in many eukaryotic
genes (Bradnam and Korf, 2008), the first intron is the
longest one found in the MAPT gene likely because it harbors
cis regulatory sequences (Chorev and Carmel, 2012). MAPT
promoter presents two main characteristic: absence of TATA and
CAAT boxes and a big G+C content (Gao et al., 2005). Thus,
methylation of CpG islands present in exon and intron 0 can
modulate tau expression likely altering accessibility to binding
factors and transcription initiation factors (Caillet-Boudin et al.,
2015). With these ideas in mind, it is tempting to speculate that
rs62056842 SNP might affect that regulatory system. In fact CpG
island close to rs242557 SNP is hypomethylated in PSP (Huin
et al., 2016) and H1 haplotype increases risk for tauopathy via
differential methylation (Li et al., 2014).
In addition, taking into account that this first intron harbors
several ncRNA it can be hypothesized that the above mentioned
SNP could alter some of them. MAPT-AS1 is an 840 bp long
ncRNA transcribed from the anti-sense strand of the MAPT
which has an inhibitory effect on MAPT promoter activity
(Coupland et al., 2016). Interestingly, a significant decrease in
MAPT-AS1 expression has been observed in PD (Coupland et al.,
2016). Thus, it might be suggested that considering that the
rs62056842 is close to the MAPT-AS1 promoter, its expression
can be modulated by that particular SNP.
The study here commented on by Okbay et al. has only
examined people of European ancestry and it is unclear
whether the observed results apply to those with roots in
other regions (Figure 1B). In fact, the 1000 genomes project
(www.ncbi.nlm.nih.gov/variation/tools/1000genomes/) shows
that, although rs62056842 presents an allele frequency of T =
0.9147 and G= 0.0853, being the allele T the one associated with
higher values of educational attainment in the meta-analysis
carried out by the authors, that frequency shows great variation
and, for example, it is not present in people from Africa or China
where T = 1. Overall, this study shows the importance of tau
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protein not only in learning, as different animal models have
demonstrated, but also in educational attainment, being one of
the genetic factors involved.
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